Medicine and Dentistry
Vincristine
100%
Verapamil
58%
Plasma
23%
Tissues
17%
Small Intestine
17%
Xenograft
11%
Toxicity
11%
Pharmacokinetics
11%
Effusion
11%
Lethality
11%
Pump
11%
Neoplasm
5%
Steady State
5%
In Vitro
5%
Phenotype
5%
Infusion
5%
Tumor Xenograft
5%
Peritoneal Cavity
5%
Calcium Channel Blocking Agent
5%
Multidrug Resistance
5%
Rhabdomyosarcoma
5%
Drug
5%
Chemotherapeutic Agent
5%
Xenobiotic Agent
5%
Parent
5%
Pharmacology, Toxicology and Pharmaceutical Science
Vincristine
100%
Verapamil
58%
Mouse
29%
Toxicity
11%
Pharmacokinetics
11%
Effusion
11%
Lethality
11%
Elimination
11%
Neoplasm
5%
Xenobiotic Agent
5%
Drug
5%
Rhabdomyosarcoma
5%
Immunology and Microbiology
Mouse
29%
Dose
23%
High Performance Liquid Chromatography
23%
Blood Level
17%
Xenograft
17%
Small Intestine
17%
Tissues
17%
Modulation
11%
Pharmacokinetics
11%
Phenotype
5%
Peritoneal Cavity
5%
Steady State
5%
Blood Plasma
5%
Multidrug Resistance
5%
Xenobiotic
5%
Maximum Concentration
5%
Extract
5%
Contrast
5%
Liver
5%
Reduction (Chemistry)
5%
Kidney
5%
Biochemistry, Genetics and Molecular Biology
Verapamil
58%
Mouse
29%
Dose
23%
Blood Level
17%
Modulation
11%
Pharmacokinetics
11%
Calcium Channel Blocker
11%
Steady State
5%
Phenotype
5%
Maximum Concentration
5%
Multidrug Resistance
5%
Contrast
5%
Reduction (Chemistry)
5%
Extract
5%
Veterinary Science and Veterinary Medicine
Verapamil
58%
Peritoneal Cavity
5%
Liver
5%
Kidney
5%
Rhabdomyosarcoma
5%
Calcium Channel Blocker
5%